U.S. Customs Rule Tightens Canadian Drug Imports Starting October 22

Starting October 22, U.S. Customs and Border Protection will enforce a new rule requiring prescription drug shipments valued over $100 from Canada to be declared before import. The change eliminates a decades-old loophole that allowed Americans to import medications under $800 with minimal scrutiny. Millions of uninsured and underinsured Americans rely on Canadian pharmacies to afford drugs unavailable or unaffordable domestically, and the rule threatens to cut off this access.

What the new rule requires

The new order mandates that shipments over $100 must go through a customs process requiring a licensed customs broker and an entry bond. Previously, packages under $800 could be imported with basic inspection only. The rule takes effect October 22, 2026. This adds cost and complexity to personal drug imports that were once straightforward.

Who this affects most

Uninsured and underinsured Americans have used Canadian pharmacies as a lifeline for decades. One patient reported jumping from $30 for three months of medication to $400 after losing Canadian access, forcing her to cut doses in half. Common imports include Eliquis, a blood thinner. Congressional lawmakers have urged the Trump administration to reconsider the rule over concerns it will prevent access to affordable medicines.

Why the rule exists despite legal gray area

Importing prescription drugs to the U.S. is illegal in most cases because they lack FDA approval. However, enforcement has been inconsistent for years. The new rule represents a formal tightening of enforcement, making it harder for Canadian pharmaceutical companies to serve U.S. customers. Gabriel Levitt, Founder of Prescription Justice, called Canadian imports a lifeline for those whose prescriptions are not covered by insurance.

What comes next

The rule begins October 22. Patients currently importing medications face a choice: pay higher U.S. prices, stretch prescriptions, or take less than prescribed. Darren Covington, Executive Vice President of the Indiana Pharmacy Association, noted the previous $800 threshold made imports accessible. The new $100 declaration threshold and broker requirement will likely reduce cross-border drug purchases significantly.

Final Thoughts

The October 22 rule closes a decades-old access point for uninsured Americans seeking affordable medications. For patients on fixed incomes, the impact could be severe. Monitor whether Congress acts to delay or modify the rule before the deadline.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.